StemCells, Inc.
Biotechnology ResearchNew Jersey, United States51-200 Employees
StemCells, Inc. operates in the biotechnology research sector, focusing on clinical development of purified human neural stem cells for potential treatments of neurological and retinal disorders. Its work centers on advancing cell-based therapies through Phase I/II and Phase II trials, with early data indicating safety and signs of functional or sensory improvements in spinal cord injury and improvements in visual function for certain retinal diseases. The company’s activities are aimed at addressing complex central nervous system and retinal conditions, serving medical researchers and healthcare providers seeking regenerative treatment options for patients with these disorders. Based in Newark, New Jersey, the firm is positioned as a developer of stem cell–based therapeutics within the broader biotechnology landscape, pursuing multiple investigative pathways and clinical studies to establish therapeutic potential across indications. A notable recent development is the company’s merger with Microbot Medical, after which the combined entity began trading under the Microbot Medical name.
1-888-653-2347 
support@leadiq.com 
